(Q40444939)

20 September 2017

title

Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands (English)

1 reference

20 September 2017

0 references

1 reference

Monique K van der Kooij

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Ellen Kapiteijn

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

8

C U Blank

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

A Joosse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

F M Speetjens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

G A P Hospers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

C Bisschop

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

J W B de Groot

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

R Koornstra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

2 December 2016

1 reference

20 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

101-103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Radiofrequency ablation in metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Transarterial chemoembolization of liver metastases in patients with uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

The use of pembrolizumab for the treatment of metastatic uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0284186X.2016.1260773

10.1080/0284186X.2016.1260773

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27911126%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1 reference